Tango Therapeutics Inc (TNGX)
6.91
-0.18
(-2.54%)
USD |
NASDAQ |
May 24, 16:00
6.90
-0.01
(-0.14%)
After-Hours: 20:00
Tango Therapeutics Enterprise Value: 394.71M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 394.71M |
| May 23, 2024 | 413.94M |
| May 22, 2024 | 446.00M |
| May 21, 2024 | 454.54M |
| May 20, 2024 | 475.91M |
| May 17, 2024 | 459.89M |
| May 16, 2024 | 488.73M |
| May 15, 2024 | 489.80M |
| May 14, 2024 | 468.43M |
| May 13, 2024 | 437.45M |
| May 10, 2024 | 415.54M |
| May 09, 2024 | 486.60M |
| May 08, 2024 | 501.56M |
| May 07, 2024 | 495.14M |
| May 06, 2024 | 499.42M |
| May 03, 2024 | 469.50M |
| May 02, 2024 | 467.36M |
| May 01, 2024 | 433.43M |
| April 30, 2024 | 478.26M |
| April 29, 2024 | 496.41M |
| April 26, 2024 | 450.51M |
| April 25, 2024 | 438.77M |
| April 24, 2024 | 484.67M |
| April 23, 2024 | 485.74M |
| April 22, 2024 | 436.64M |
| Date | Value |
|---|---|
| April 19, 2024 | 436.64M |
| April 18, 2024 | 443.04M |
| April 17, 2024 | 452.65M |
| April 16, 2024 | 440.91M |
| April 15, 2024 | 437.70M |
| April 12, 2024 | 441.97M |
| April 11, 2024 | 466.52M |
| April 10, 2024 | 453.71M |
| April 09, 2024 | 478.26M |
| April 08, 2024 | 449.41M |
| April 05, 2024 | 444.07M |
| April 04, 2024 | 471.82M |
| April 03, 2024 | 476.09M |
| April 02, 2024 | 463.29M |
| April 01, 2024 | 471.82M |
| March 31, 2024 | 503.84M |
| March 28, 2024 | 510.46M |
| March 27, 2024 | 484.85M |
| March 26, 2024 | 464.57M |
| March 25, 2024 | 477.38M |
| March 22, 2024 | 488.05M |
| March 21, 2024 | 540.34M |
| March 20, 2024 | 570.22M |
| March 19, 2024 | 532.87M |
| March 18, 2024 | 558.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-130.14M
Minimum
Sep 26 2022
1.323B
Maximum
Sep 17 2021
325.74M
Average
290.96M
Median
Nov 07 2022
Enterprise Value Benchmarks
| Cytokinetics Inc | 5.064B |
| Aquestive Therapeutics Inc | 212.16M |
| 2seventy bio Inc | 50.46M |
| NovaBay Pharmaceuticals Inc | 5.655M |
| Palatin Technologies Inc | 22.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -37.91M |
| Revenue (Quarterly) | 6.471M |
| Total Expenses (Quarterly) | 48.73M |
| EPS Diluted (Quarterly) | -0.35 |
| Profit Margin (Quarterly) | -585.9% |
| Earnings Yield | -16.06% |
| Normalized Earnings Yield | -16.06 |